These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21510723)

  • 1. New frontiers in pulmonary hypertension.
    Rubin LJ; Morrell NW
    Expert Rev Respir Med; 2011 Apr; 5(2):139-40. PubMed ID: 21510723
    [No Abstract]   [Full Text] [Related]  

  • 2. Levosimendan and pulmonary hypertension.
    Cavusoglu Y; Beyaztas A; Birdane A; Ata N
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805
    [No Abstract]   [Full Text] [Related]  

  • 3. Tadalafil (Adcirca) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2009 Nov; 51(1324):87-8. PubMed ID: 19890245
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension secondary to interstitial lung disease.
    Shlobin OA; Nathan SD
    Expert Rev Respir Med; 2011 Apr; 5(2):179-89. PubMed ID: 21510729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-altitude pulmonary hypertension: effects of captopril on pulmonary and systemic arterial pressures.
    Niazova ZA; Batyraliev TA; Aikimbaev KS; Kudaiberdieva GZ; Akgul F; Soodanbekova YK; Birand A
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S141-2. PubMed ID: 8872846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
    Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
    Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy in pulmonary arterial hypertension: do we have the right strategy?
    Mukherjee B; Howard L
    Expert Rev Respir Med; 2011 Apr; 5(2):191-205. PubMed ID: 21510730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of terlipressin in the management of severe pulmonary hypertension in congenital diaphragmatic hernia.
    Papoff P; Caresta E; Versacci P; Grossi R; Midulla F; Moretti C
    Paediatr Anaesth; 2009 Aug; 19(8):805-6. PubMed ID: 19624374
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the endothelium in pulmonary arterial hypertension.
    Haworth SG
    Vascul Pharmacol; 2006 Nov; 45(5):317-25. PubMed ID: 17005453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.
    Hagan G; Pepke-Zaba J
    Expert Rev Respir Med; 2011 Apr; 5(2):163-71. PubMed ID: 21510727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreword.
    Rahimtoola SH
    Curr Probl Cardiol; 2011 Dec; 36(12):459. PubMed ID: 22035607
    [No Abstract]   [Full Text] [Related]  

  • 14. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview.
    Raja SG
    Cardiovasc Ther; 2010 Oct; 28(5):e65-71. PubMed ID: 20406243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol.
    Frost AE; Quiñones MA; Zoghbi WA; Noon GP
    J Heart Lung Transplant; 2005 Apr; 24(4):501-3. PubMed ID: 15797757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension.
    Freed DH; Thomson BM; Berman M; Tsui SS; Dunning J; Sheares KK; Pepke-Zaba J; Jenkins DP
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):383-7. PubMed ID: 20471039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension update.
    Hesselgrave B
    Case Manager; 2005; 16(6):61-6; quiz 67. PubMed ID: 16326325
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of portopulmonary hypertension--isn't it time to move forward?
    Swanson KL
    Liver Transpl; 2008 Mar; 14(3):270-1. PubMed ID: 18306388
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition.
    Duffels M; van Loon L; Berger R; Boonstra A; Vonk-Noordegraaf A; Mulder B
    Congenit Heart Dis; 2007; 2(4):242-9. PubMed ID: 18377475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive winds of change for pulmonary hypertension. New treatments offer help and hope for people with high blood pressure in the lungs.
    Harv Heart Lett; 2004 Oct; 15(2):5-6. PubMed ID: 15496364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.